HomeProductsBuilding BlocksHeterocyclic ScaffoldsThiophene CompoundsRotigotine
Chemical structure of CAS 99755-59-6

Rotigotine

CAS No.99755-59-6
MDL No.MFCD00870193
MFC19H25NOS
MW315.50
InChI KeyKFQYTPMOWPVWEJ-INIZCTEOSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Rotigotine is a tetralin derivative.

CAS No.99755-59-6
Product NameRotigotine

Biological Targets

DRD2·DRD3·DRD4

Associated Conditions

drug dependence·Alzheimer disease·restless legs syndrome·Parkinson disease·stroke·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Rotigotine transdermal patch for the treatment of Parkinson's Disease.

Fundamental & clinical pharmacology • Vol. 27, Issue 1 • 2013
PMID: 22320451DOI: 10.1111/j.1472-8206.2012.01028.x

ADMET considerations for restless leg syndrome drug treatments.

Expert opinion on drug metabolism & toxicology • Vol. 8, Issue 10 • 2012
PMID: 22808933DOI: 10.1517/17425255.2012.708023

Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease.

Pharmacotherapy • Vol. 29, Issue 12 • 2009
PMID: 19947805DOI: 10.1592/phco.29.12.1452

Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole.

Movement disorders : official journal of the Movement Disorder Society • Vol. 22, Issue 16 • 2007
PMID: 17935234DOI: 10.1002/mds.21741

Documentation

Similar Products